594 related articles for article (PubMed ID: 16322686)
1. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
2. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats.
Pogribny IP; Ross SA; Tryndyak VP; Pogribna M; Poirier LA; Karpinets TV
Carcinogenesis; 2006 Jun; 27(6):1180-6. PubMed ID: 16497704
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets.
Chekhun VF; Lukyanova NY; Kovalchuk O; Tryndyak VP; Pogribny IP
Mol Cancer Ther; 2007 Mar; 6(3):1089-98. PubMed ID: 17363502
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
5. Impact of Histone Lysine Methyltransferase SUV4-20H2 on Cancer Onset and Progression with Therapeutic Potential.
Papadaki S; Piperi C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473745
[TBL] [Abstract][Full Text] [Related]
6. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
[TBL] [Abstract][Full Text] [Related]
7. Preferential dimethylation of histone H4 lysine 20 by Suv4-20.
Yang H; Pesavento JJ; Starnes TW; Cryderman DE; Wallrath LL; Kelleher NL; Mizzen CA
J Biol Chem; 2008 May; 283(18):12085-92. PubMed ID: 18296440
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
9. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
10. Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype.
Simpson NE; Tryndyak VP; Pogribna M; Beland FA; Pogribny IP
Epigenetics; 2012 Dec; 7(12):1413-20. PubMed ID: 23117580
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.
Zhou Q; Atadja P; Davidson NE
Cancer Biol Ther; 2007 Jan; 6(1):64-9. PubMed ID: 17172825
[TBL] [Abstract][Full Text] [Related]
12. Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination.
Benetti R; Gonzalo S; Jaco I; Schotta G; Klatt P; Jenuwein T; Blasco MA
J Cell Biol; 2007 Sep; 178(6):925-36. PubMed ID: 17846168
[TBL] [Abstract][Full Text] [Related]
13. Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents.
Pogribny IP; Tryndyak VP; Pogribna M; Shpyleva S; Surratt G; Gamboa da Costa G; Beland FA
Int J Oncol; 2013 May; 42(5):1822-32. PubMed ID: 23483119
[TBL] [Abstract][Full Text] [Related]
14. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase.
Fuks F; Hurd PJ; Deplus R; Kouzarides T
Nucleic Acids Res; 2003 May; 31(9):2305-12. PubMed ID: 12711675
[TBL] [Abstract][Full Text] [Related]
15. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin.
Schotta G; Lachner M; Sarma K; Ebert A; Sengupta R; Reuter G; Reinberg D; Jenuwein T
Genes Dev; 2004 Jun; 18(11):1251-62. PubMed ID: 15145825
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.
Arabsolghar R; Azimi T; Rasti M
Mol Biol Rep; 2013 Mar; 40(3):2617-25. PubMed ID: 23242655
[TBL] [Abstract][Full Text] [Related]
17. Fractionated low-dose radiation exposure leads to accumulation of DNA damage and profound alterations in DNA and histone methylation in the murine thymus.
Pogribny I; Koturbash I; Tryndyak V; Hudson D; Stevenson SM; Sedelnikova O; Bonner W; Kovalchuk O
Mol Cancer Res; 2005 Oct; 3(10):553-61. PubMed ID: 16254189
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo.
Yokoyama Y; Hieda M; Nishioka Y; Matsumoto A; Higashi S; Kimura H; Yamamoto H; Mori M; Matsuura S; Matsuura N
Cancer Sci; 2013 Jul; 104(7):889-95. PubMed ID: 23557258
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
20. Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity.
Jørgensen S; Schotta G; Sørensen CS
Nucleic Acids Res; 2013 Mar; 41(5):2797-806. PubMed ID: 23345616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
